News How AztraZeneca CEO Pascal Soriot is navigating a vaccine...

How AztraZeneca CEO Pascal Soriot is navigating a vaccine storm


Around midnight on Tuesday, battered by the latest furor over his company’s life-saving Covid vaccine, Pascal Soriot, chief executive of AstraZeneca, sent an email to a friend.

His reputation now rests on whether his grand ambition to bring a not-for-profit Covid-19 vaccine to the world – “The biggest CSR project in history” as one company insider describes it – becomes his defining accomplishment or a symbol of over-reach that will permanently diminish his achievement in turning AZ into one of the pharma industry’s global powerhouses.

A key moment came in 2009 when he was appointed CEO of Genentech, the California-based biotechnology company which had been acquired by Swiss pharma group Roche.

Read full article here

Latest news

Patient-Centric Clinical Trials And The Role Of A Travel Concierge

Many people find booking plane tickets, arranging road transportation and overnight lodging overwhelming. Add into that mix...

China forces insulin price cuts resulting in pullback for global pharma players

Xinhua, a Chinese news channel, commented on the price cut on insulin which was brought on by...

Aussie pharma CSL in talks to buy Swiss firm Vifor Pharma for USD 7B

CSL, the Australian giant, is in talks to buy Vifor Pharma in a deal that is valued...
- Advertisement -

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC

You might also likeRELATED
Recommended to you